DS-8201 Strategic Collaboration

from the beginning

DS-8201 Strategic Collaboration

Forward-Looking Statements

DS-8201 Strategic Collaboration

• 1.Overview

DS-8201 Strategic Collaboration Overview-1

DS-8201 Strategic Collaboration Overview-2

Financial Terms of DS-8201 Collaboration

• 2.Significance

Significance of the Collaboration

Accelerate DS-8201 Commercialization & Development

Early Market Penetration through Collaboration

Accelerate and Expand Development through Collaboration

Building DS-8201 in Breast Cancer and Beyond

Maximize the Product Value of DS-8201

Accelerate Establishment of DS Global Oncology Infrastructure

Expand Resource Allocation for Other ADC Programs

Summary

DS-8201: Acceleration of BLA Submission in U.S.

DS-8201: Acceleration of BLA Submission in U.S.

Contact address regarding this material

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6

• Q&A 7

• Q&A 8

• Q&A 9

• Q&A 10

• Q&A 11

• Q&A 12

• Q&A 13